A CB2 Agonist Alleviates Liver Fibrosis by Downregulating the ERK1/2 Signalling Pathway in Mouse Hepatic Fibrosis Model
Preprint in Research Square (December 2023)
The most recent citing publications are shown below. View all 45 publications that cite this research output on Dimensions.
The Material World of 3D‐Bioprinted and Microfluidic‐Chip Models of Human Liver Fibrosis
Article in Advanced Materials (November 2023)
Integrating Concentration-Dependent Toxicity Data and Toxicokinetics To Inform Hepatotoxicity Response Pathways
Article in Environmental Science and Technology (August 2023)